BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 32554751)

  • 21. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.
    Sinha P; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3.
    Ma M; Huang W; Kong D
    Int Immunopharmacol; 2018 Jun; 59():148-156. PubMed ID: 29655056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
    Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I
    Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.
    Redd PS; Ibrahim ML; Klement JD; Sharman SK; Paschall AV; Yang D; Nayak-Kapoor A; Liu K
    Cancer Res; 2017 Jun; 77(11):2834-2843. PubMed ID: 28381543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A RIPK3-PGE
    Yan G; Zhao H; Zhang Q; Zhou Y; Wu L; Lei J; Wang X; Zhang J; Zhang X; Zheng L; Du G; Xiao W; Tang B; Miao H; Li Y
    Cancer Res; 2018 Oct; 78(19):5586-5599. PubMed ID: 30012671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
    Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
    Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
    Wang L; Hu D; Xie B; Xie L
    Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling.
    Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF
    Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic Component p66a Modulates Myeloid-Derived Suppressor Cells by Modifying STAT3.
    Xin J; Zhang Z; Su X; Wang L; Zhang Y; Yang R
    J Immunol; 2017 Apr; 198(7):2712-2720. PubMed ID: 28193828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
    Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
    J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Lung Cancer by 2-Methoxy-6-Acetyl-7-Methyljuglone Through Induction of Necroptosis by Targeting Receptor-Interacting Protein 1.
    Sun W; Yu J; Gao H; Wu X; Wang S; Hou Y; Lu JJ; Chen X
    Antioxid Redox Signal; 2019 Jul; 31(2):93-108. PubMed ID: 30556404
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure.
    Zhou L; Miao K; Yin B; Li H; Fan J; Zhu Y; Ba H; Zhang Z; Chen F; Wang J; Zhao C; Li Z; Wang DW
    Circulation; 2018 Jul; 138(2):181-197. PubMed ID: 29437117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors.
    Hellsten R; Lilljebjörn L; Johansson M; Leandersson K; Bjartell A
    Prostate; 2019 Oct; 79(14):1611-1621. PubMed ID: 31348843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin-induced necroptosis in TNFα dependent and independent pathways.
    Xu Y; Ma HB; Fang YL; Zhang ZR; Shao J; Hong M; Huang CJ; Liu J; Chen RQ
    Cell Signal; 2017 Feb; 31():112-123. PubMed ID: 28065786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin.
    Suk Lee Y; Davila E; Zhang T; Milmoe HP; Vogel SN; Bromberg JS; Scalea JR
    Innate Immun; 2019 Jan; 25(1):46-59. PubMed ID: 30782043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Akt Regulates TNFα synthesis downstream of RIP1 kinase activation during necroptosis.
    McNamara CR; Ahuja R; Osafo-Addo AD; Barrows D; Kettenbach A; Skidan I; Teng X; Cuny GD; Gerber S; Degterev A
    PLoS One; 2013; 8(3):e56576. PubMed ID: 23469174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.
    Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ
    Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
    J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
    Front Immunol; 2020; 11():613215. PubMed ID: 33679700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.